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Abstract  
Diversity-Oriented Synthesis (DOS), also known as combinatorial synthesis, is a process, by which 
multiple compounds are generated simultaneously, in a predictable fashion using techniques that 
involve parallel chemical transformations. Through diversity-oriented synthesis organic chemists are 
now able to achieve more structural complexity than in the early days of combinatorial chemistry. 
Combinatorial chemistry techniques offer unique enhancement in the potential identification of new 
and/or therapeutic candidates. Over the past fifteen years in the design and diversity oriented synthesis 
of low molecular weight acyclic and heterocyclic combinatorial libraries derived from amino acids, 
peptides and/or peptidomimetics are described. Employing a “toolbox” of various chemical 
transformations, the “libraries from libraries” concept has enabled the continued development of an 
ever-expanding, structurally varied, series of organic chemical libraries.   
 
Keywords: chemical transformations; DOS; peptides. 
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1. Introduction  
One of the central objectives of organic and medicinal 
chemistry is the design, synthesis, and production of 
molecules having value as human therapeutic agents.  
Historically, the identification of such compounds has been 
carried out using compounds from plant and animal tissue 
extracts, microbial broth extracts, as well as individual 
compound collections resulting from fifty years of effort by 
synthetic chemists in academic and pharmaceutical 
organizations. Compounds having multiple stereocenters 
and complex, natural product-like properties are now being 
increasingly prepared. The preparation of structurally 
complex and diverse compounds results in a broader 
expansion of chemical space and facilitates effective 
probing of biological space. Such structural complexity is 
clearly significant because many of the small molecules 
known to disrupt protein-protein interactions are complex 
natural products or natural product-like compounds, 
increasing the potential for therapeutic development. 
Diversity-oriented synthesis approaches have created a vast 
new source of molecular diversity for the potential 
identification of lead compounds. Merrifield’s solid phase 
synthetic methods presented in 1963[1, 2] were accelerated 
by techniques developed by Frank, Geysen, and Houghten 
for the combinatorial synthesis of oligonucleotides and 
peptides on cellulose disks[3, 4] pins and standard resins in 
mesh packets (the “teabag” approach)5 in 1983, 1984 and 
1985, respectively [5]. The versatility and increased 
capability afforded by the teabag approach, first developed 
for solid phase peptide synthesis, has led to the 
identification of a wide range of bioactive peptides, 
including novel antibacterials, potent opioid receptor 
agonists and antagonists, inhibitors of melittin’s hemolytic 
activity, antigenic peptides recognized by monoclonal 
antibodies, and potent endothelin antagonists[6, 7].  The 
next level of successful diversity generation involved the 
use of soluble mixture-based synthetic combinatorial 
libraries (SCLs) made up of tens of millions of compounds. 
These libraries have been successfully used for the de novo 
identification of potent analgesics[8-12] antimicrobial 
agents[13, 14] enzyme inhibitors, antitumoral, and highly 
specific antigenic determinants of B-cells and T-cells [15]. 
Along with linear peptide sequences, our laboratory and 
other groups have also synthesized combinatorial libraries 
of cyclic peptides [16-23].  In the last decade, the focus of 
combinatorial chemistry has shifted to libraries of small 
molecule compounds having molecular weights of 500 
Dalton or less [24, 25]. Employing a “toolbox”of  various 
chemical transformations, including alkylation, oxidation, 
reduction, acylation, and the use of a variety of 
multifunctional reagents, we present examples of the use of 
the “libraries from libraries” concept for the development 
and generation of an ever-expanding, structurally varied, 
series of organic chemical libraries.  
2. Synthesis of low molecular weight acyclic compounds  
Early work from our laboratory has shown the utility of 
mixture-based chemical libraries of small molecules for the 
de novo identification of highly active antimicrobial 
compounds, novel antitumor agents [8] and potent 
analgesics [7]. These libraries represent chemical collections 
of low molecular weight heterocyclic and acyclic 
compounds. The diversity of these chemical structures, as 
well as the large number of compounds making up each 
class of structures, greatly increases the probability of 
identifying compounds having useful chemical 
characteristics. 
Due to the well-understood chemistry and excellent 
synthetic purity and yields obtained during the solid phase 
synthesis of peptides, our primary efforts have  been 
directed toward the synthesis and design of acyclic and 
heterocyclic compounds using resin-bound amino acids, 
peptides and peptidomimetics as starting materials [ 7, 37] 
A range of peptide and peptidomimetic libraries have been 
modified using a variety of chemical reagents (acylation, 
alkylation, reduction, etc.) to generate an ever-expanding 
range of chemical diversities having strikingly different 
physicochemical properties relative to their starting 
libraries[46-49]. such new libraries can, in turn, be used to 
generate further libraries. The continually expanding 
combination of such chemical alterations permits the 
creation of a “toolbox” of chemical transformations for the 
generation of immense diversities of compounds. Thus, for 
the last decade, this strategy has been successfully used to 
design and generate a range of novel solid phase 
chemistries. We initially developed efficient strategies for 
the generation of peptidomimetic libraries by the alkylation 
and/or reduction of the amides of existing short peptide 
libraries[46-51] Initial examples of this approach, termed 
“libraries from libraries,”48 are shown in Scheme 1 in which 
peralkylation and/or exhaustive reduction of the amide 
bonds in peptides yield completely different classes of 
compounds such as peptidomimetics 1 and polyamines 2. 
Polyamines were treated with different carboxylic acids or 
isocyanates to afford following cleavage of the resin the 
corresponding per-acylated amines 3, or polyisocyanates 4, 
respectively.  
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Scheme 1. Generation of peptidomimetic and small molecule libraries. 
 
 
 
 
A vital modification of the peptide backbone was the 
exhaustive reduction of amide bonds leading to chiral 
polyamines [50, 51]. Polyamines have been shown to be 
pharmacologically unique compounds [52]. They are also 
ideally suited to bind DNA.52 Multiple amine functionalities 
are common in drugs active within the central nervous 
system. They constitute one of a few classes of compounds 
capable of interacting with the three natural biopolymers: 
proteins, nucleic acids and oligosaccharides[52, 53]. 
Polyamines interact strongly with nucleic acids and play an 
important role in their biosynthesis and metabolism[54]. A 
variety of mixture-based combinatorial libraries made up of 
different numbers of polyamines, as well as large arrays of 
individual polyamines have been synthesized in our 
laboratory [7, 50]. Those libraries have been screened 
internally and in collaboration with outside collaborators. 
Examples of reported activities include antimalarial, 
antitubercular, HIV inhibitory and antitumoral activities [7, 
8 ,55, 56]. The exhaustive reduction of peptides and chiral 
polyamides on solid-supports, introduced by our laboratory, 
has been utilized in a wide range of synthetic procedures. 
Typical reaction conditions for the solid-phase reduction of 
polyamides consist of the 72 hour treatment of resin-bound 
peptides with BH3-THF at 65°C [50,51] The generated 
resin-bound borane-amine complexes are then disproportion 
 
 
 
-ate following overnight treatment with neat piperidine at 
65°C. Peralkylated chiral amines and/or selectively 
alkylated amines have been successfully generated by 
exhaustive reduction of peralkylated peptides and 
peptidomimetics. Resin-bound chiral polyamines have been 
further used as templates for the generation of chiral acyl-
polyamines, poly-N-acylamines, polyureas and 
polythioureas libraries[37, 57-59]. 
 
III. Synthesis of heterocyclic compounds from resin-
bound amino acids and/or resin-bound-short peptides. 
The reaction of the N-terminal amino group of a 
resin-bound dipeptide with carbonyldiimidazole or 
thiocarbonyldiimidazole led to an intermediate isocyanate 
(or isothiocyanate) that further reacts intramolecularly to 
form the five-membered ring hydantoin 5 (or thiohydantoin 
6 (Scheme 2) [59]. We have also synthesized branched 
hydantoins 7 and branched thiohydantoins 8 starting from 
resin-bound orthogonally protected diamino acids (amino 
acids having two amine functionalities). Following coupling 
of the second amino acid and hydantoin (or thiohydantoin) 
formation, the side chain of the diamino acid was 
deprotected and the free amino group then N-acylated with a 
range of carboxylic acids or isocyanates to yield, following 
cleavage of the solid support, the corresponding branched 
hydantoins (or thiohydantoins).  
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Scheme 2. Synthesis of hydantoins and thiohydantoins libraries. 
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Scheme 3.  Synthesis of different amino-imidazolones. 
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Scheme 4.  Synthesis of imidazo-imidazolones and imidazopyridoindoles.
 
 
Starting from resin-bound amino acids, the 
treatment of the N-terminal amine with isothiocyanate 
provided a thiourea that, in the presence of HgCl2 and a 
primary or secondary amine, generated the resin-bound 
guanidines. Cleavage from the solid support with HF 
generates the 2, 3, 4-trisubstituted 4H-imidazolones 9 
following an  intramolecular cyclization via an “Edman-
like” degradation (Scheme 3). The reaction of resin-bound 
thiourea with Mukayama’s reagent resulted in the formation 
of the carbodiimide intermediate that undergoes 
intramolecular cyclization to yield, following cleavage of 
the solid support,  the 2-amino imidazolidin-4-ones 10 
(Scheme 3) [60,61]  
 
 
Functional amino acid side chains were also used for 
the synthesis of different heterocyclic compounds. The 
parallel synthesis of 1,3,4,7-tetra substituted perhydro-l,4-
diazepine-2,5-diones 13 (Scheme 5) was performed starting 
from the Fmoc-protected resin-bound t-butyl ester of 
aspartic acid. 
The treatment of resin-bound acylated dipeptides with 
freshly distilled phosphorous oxychloride (POCl3) led to the 
formation of bicyclic [3,5,7]-1H-imidazo[1,5-a]-imidazol-
2(3H)-ones 11 (Scheme 4) [62]. Under the same reaction 
conditions, and starting from resin-bound N-acylated 
dipeptides having tryptophan (or Trp analog) as the C-
terminal amino acid generated following treatment with 
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(POCl3) and double cyclodehydration under Bischler–
Napieralski conditions [63] the fused tricyclic 
imidazopyridoindole 12. A large number of individual 
imidazopyridoindoles was obtained following hydrogen 
fluoride (HF) cleavage (Scheme 4) [64].   
 
Following deprotection of the Fmoc group, the amine 
was reductively alkylated. An Fmoc amino acid was then 
coupled, and a second reductive alkylation was performed 
following Fmoc deprotection. The t-butyl group was cleaved 
and an intramolecular amidation occurred in the presence of 
HATU to afford the desired trisubstituted diazepinediones.  
Separately, starting from resin-bound Fmoc-Cys(Trt)-
OH, the solid-phase synthesis of 2,4,5-trisubstituted 
thiomorpholin-3-ones 14 was achieved following 
deprotection of the side chain, reductive alkylation, and 
intramolecular amide formation (Scheme 5).65 Similarly, 
starting from resin-bound cysteine and following reaction of 
the deprotected cysteine side chain with 2-fluoro-5-
nitrobenzoic acid, followed by reductive alkylation and 
intramolecular cyclization, the l,4-benzothiazepin-5-one 
derivatives 15 were obtained in good yield and high purity 
(Scheme 6)[66]. 
IV. Synthesis of diazacyclic compounds from resin-
bound chiral polyamines 
Following exhaustive reduction of the resin-bound 
polyamides, the resulting chiral polyamines can be used as 
templates for the solid phase synthesis of highly diverse 
individual compound arrays and mixture-based 
combinatorial libraries.[7,50,67-81]. Various disubstituted 
heterocyclic compounds were prepared from resin-bound N-
acylated amino acid amides (Scheme 7). Thus, following 
reduction of the two amides, the resulting resin-bound 
diamines was treated with commercially available 
bifunctional reagents such as carbonyldiimidazole, 
thiocarbonyldiimidazole, cyanogen bromide, 
oxalyldiimidazole, malonyl chloride, and benzyl 
isocyanatidocarbonate to afford following HF cleavage, the 
corresponding disubstituted imidazolinones 16, 
imidazolidinethiones 17, cyclic guanidines 18,  
diketopiperazines 19, piperazines 20, diazepinediones 21, 
and triazinediones 22, respectively. 
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Scheme 5. Synthesis of diazepinediones from resin-bound aspartic acid. 
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Scheme 6. Synthesis of thiomorpholinones and benzothiazepines from resin-bound cysteine. 
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Scheme 7. Synthesis of trisubstituted diaza- and triaza-cyclic compounds from resin-bound diamines. 
 
We extended our approach to the parallel solid-phase 
synthesis of the trisubstituted heterocyclic analogs starting 
from selectively N-alkylated resin-bound triamines. The free 
N-terminal amino functionalities of resin-bound amino acids 
were protected with triphenylmethyl chloride (TrtCl). The 
secondary amides linked to the solid support were then 
selectively alkylated in the presence of lithium t-butoxide 
and an alkyl halide. As anticipated, alkylation of the amide 
nitrogen of the resin linkage dramatically increased the acid 
sensitivity of the MBHA resin-bound peptide, excluding the 
use of Boc-amino acids in further couplings. Therefore, 
Fmoc-amino acids were employed in subsequent couplings. 
Following Fmoc removal and N-acylation of the resin-
bound dipeptide, exhaustive reduction of the amide bonds 
using borane in tetrahydrofuran again yielded the desired 
resin-bound chiral triamine 23 having two available 
secondary amines and one tertiary amine [51]. 
 
Treatment of the triamine with the previously described 
bifunctional reagents yielded, following HF cleavage, the 
corresponding trisubstituted heterocyclic compounds. 
Scheme 8 illustrates the approach for the solid phase 
synthesis of the triamine template 23. Following the strategy 
described in Scheme 8, various heterocyclic SCLs 24 were 
prepared in positional scanning format 82 containing the 
aforementioned heterocycles. The solid phase synthesis of 
bicyclic guanidine 25 from resin-bound triamines (three 
seconday amines), which itself was derived from an N-
acylated dipeptide. Following addition of 
thiocarbonyldiimidazole to form the cyclic thioureas 
described above, the presence of a third secondary amine 
permits the spontaneous formation of the bicyclic 
guanidines via a highly active intermediate.  
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Scheme 8. Synthesis of diazacyclic compounds and bis-cyclic guanidines from resin-bound reduced  
acylated dipeptides 
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Starting from glutamine-containing resin-bound N-
acylated dipeptides, and using the same strategy, tethered 
urea-linked bicyclic guanidines 26 and N-acyl amino-linked 
bicyclic guanidines 27 were prepared [75]. As outlined in 
Scheme 9, following exhaustive reduction and selective 
protection of the primary amine with a trityl group, 
treatment of the three secondary amines with hiocarbonytl- 
diimidazole generated the resin-bound bicyclic guanidine. 
Following trityl deprotection, the free primary amine was 
acylated with a wide range of carboxylic acids to yield, 
following HF cleavage, the N-acyl amino-linked bicyclic 
guanidines 27. The urea-linked bicyclic guanidine 26 library 
was obtained following trity ldeprotection,coupling of an 
amino acid, isocyanate treatment, and final HF cleavage 
(Scheme 9). 
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We have also designed and prepared resin-bound 
polyamines for the synthesis of a variety of “bis”-
heterocyclic compounds. Starting from resin-bound Fmoc-
Lys (Boc)-OH (Scheme 10), the Fmoc group was cleaved 
and the resulting free amine was N-acylated with a variety 
of carboxylic acids. Following cleavage of the Boc group 
and subsequent coupling of a Boc-amino acid and acylation, 
exhaustive reduction of the amide bonds on the solid 
support was performed using the same conditions described 
above. Treatment of the resin-bound tetraamines with 
carbonyldiimidazole, thiocarbonyldiimidazole, cyanogen 
bromide and oxalyldiimidazole resulted in the formation of 
the energetically favored five and six-membered rings, 
corresponding to the bis-cyclic ureas 28, bis-cyclic thioureas 
29, bis-cyclic guanidines 30, bis-diketopiperazines 31 and 
bis-piperazines 32[83].  Cleavage from the solid support 
with hydrogen fluoride, followed by extraction and 
lyophilization, yielded the desired bis-heterocyclic 
compounds in excellent yield and high purity.  
Extending the above mentioned approaches to larger 
polyamines, tripeptide amides were synthesized using 
conventional Boc/Bzl chemistry. Following coupling of the 
third amino acid and Boc deprotection, the resin-bound 
tripeptide was exhaustively reduced with borane in THF to 
yield resin-bound tetraamines containing three secondary 
amines and one terminal primary amine (Scheme 11). The 
resin-bound tetra-amine was then treated with bifunctional 
reagents. Excellent product purities were obtained following 
their treatment with thiocarbonyldiimidazole and cyanogen 
bromide, which afforded, following HF cleavage, the bis-
cyclic thiourea 33 and bis-cyclic guanidines 34. Kinetically, 
as expected, the primary amine reacts first with the 
thiocarbonyldiimidazole, which then favors intermolecular 
cyclization with the adjacent secondary amine to yield a 
cyclic urea due to the formation of the energetically favored 
five-membered ring. The two remaining secondary amines 
then further react with a second molecule of 
thiocarbonyldiimidazole to yield the second heterocycle. 
 
      Following optimization under various concentrations of 
thiocarbonyldiimidazole, it was observed that working at 
lower concentrations with small excesses of this reagent led 
to the desired bis-heterocyclic compounds having purities 
greater than 80% were obtained[84, 85]. Using higher 
concentrations and larger excesses of the reagent increased 
the probability that the different amines would both react 
with thiocarbonyldiimidazole and prevent the cyclization 
step. In support of our kinetic hypothesis, we found that the 
treatment of a resin-bound polyamine containing four 
secondary amines led to the formation of multiple products. 
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Scheme 10. Synthesis of bis-heterocyclic compounds from resin-bound orthogonally protected Lysine.
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V. Solid-Phase Synthesis of New Heterocyclic 
Azoniaspiro Ring Systems 
We developed an efficient approach for the parallel 
solid-phase synthesis of novel heterocyclic azoniaspiro ring 
systems. The target compounds, the 1,8,9-trisubstituted-10-
oxo-3,9-diaza-6-azoniaspiro-[5.5]undecanes, were obtained 
starting from resin-bound reduced dipeptides. The 
azoniaspiro cation was formed by intramolecular attack of a 
tertiary nitrogen on pendent α-bromocarbonyl. N-3 acylated 
and N-3 alkylamino carbonyl derivatives of the 1,8,9-
trisubstituted-10-oxo-3,9-diaza-6-azoniaspiro[5.5]undecanes 
were obtained following in solution treatment of the N-3 
azoniaspiro derivatives with different carboxylic acids and 
isocyanates.  The strategy leading to the desired 1,8,9-
trisubstituted-10-oxo-3,9-diaza-6-azoniaspiro[5.5]undecane 
35 is outlined in Scheme 12.  Starting from p-
methylbenzhydrylamine (MBHA) resin-bound dipeptide 
and following exhaustive reduction of the amide bonds,[51] 
the N-terminal primary amine was selectively protected with 
2-acetyldimedone (Dde-OH) or triphenylmethylchloride 
(Trt-Cl). The two secondary amines were treated with 
oxalyldiimidazole to generate the corresponding resin-
bound 2,3-diketopiperazines. Following cleavage of the Dde  
or Trt group, the free amine was acylated with phenyl acetic 
acid. The oxamide and amide groups were then reduced 
using BH3-THF to generate the corresponding resin-bound 
piperazine tethered secondary amine. The secondary amine 
was then coupled overnight with bromoacetic acid in the 
presence of diisopropylcarbodiimide (DIC). Following 
acylation, an intramolecular displacement of the bromo 
group occurred to yield the resin-bound diastereomeric 
mixture of the desired 1,8,9-trisubstituted-10-oxo-3,9-diaza-
6-azoniaspiro[5.5]undecane 35[38].  
Similarly, an efficient approach for the design and 
parallel solid-phase synthesis of unique tetrasubstituted 
oxopiperazinium derivatives was developed [89]. The 
synthetic procedure involved a 7-step sequence carried out 
starting from resin-bound dipeptide. The desired compounds 
were obtained in good yields and high purity. The strategy 
leading to 1,1,3,4-tetrasubstituted-5-oxopiperazin-1-ium 
salts 36 is outlined in Scheme 13. Starting from p-
methylbenzhydrylamine (MBHA) resin-bound dipeptide, 
the N-terminal primary amine was protected with 
triphenylmethyl chloride. The two secondary amides were 
methylated following treatment of the resin-bound protected 
dipeptide with lithium tert-butoxide and methyl iodide.
 
H
N N
HO
R1 H
N NH2
O
OR2
R3 H
N N
H
R1 H
N NH2
R2
R3 HN N
R2
N
NH
X
R3
X
R1
33, X= S
34, X= NH
[H]
1) CSIm2
or CNBr
2) HF
                                   Scheme 11.  Synthesis of bis-heterocyclic compounds from resin-bound tripeptides. 
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Scheme 12. Synthesis of trisubstituted azoniaspiro compounds 
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Following cleavage of the trityl protecting group, the free 
amine was acylated with a variety of carboxylic acids. The 
amide groups were then reduced using BH3-THF to generate 
the corresponding resin-bound triamines having two tertiary 
amines and one secondary amine. The secondary amine was 
then coupled with bromoacetic acid overnight in the 
presence of diisopropylcarbodiimide (DIC). Following 
acylation, an energetically favorable spontaneous 
intramolecular displacement of the bromo group occurred to 
yield the resin-bound epimeric mixture of the desired 
tetrasubstituted-5-oxopiperazinium salt. 
 
H
N
O
N
H
R1 O
NH2
R2
N
O
N
R1 O
NHTrt
R2
N
O
N
R1 O H
N
R2
R3
O
N N
R1 H
N
R2
R3 N N
R3
O
R2
HN
R1
36
1) Trt-Cl
2) LitBuO, MeI
1) TFA
2) Acylation
[H] BrCH2CO2H, DMF
 
Scheme 13. Solid-phase synthesis of tetrasubstituted oxopiperazinium. 
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Table 1. Examples of heterocyclic libraries. 
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VI. Examples of identified active compounds from small 
molecule mixture based libraries 
Table 1 summarizes a number of libraries of acyclic and 
heterocyclic compounds made using resin-bound modified 
amino acids and/or short peptides. 
To illustrate the screening and deconvolution of 
mixture-based libraries, the tri-substituted bicyclic 
guanidine positional scan synthetic combinatorial library 
(PS-SCL) [7, 50] was screened at a final concentration of 4 
µg/ml in a radio receptor binding assay specific for the 
kappa opioid receptor [7]. The library was synthesized in 
positional scan format [7]. Three sublibraries were made. 
The first sublibrary represents the 49 mixtures in which the 
R1 position is defined, the second sublibrary represents R2 
(51 mixtures) and the third sublibrary represents R3 (41 
mixtures).  Mixtures exhibiting greater than 80% inhibition 
(total of 38 mixtures from the three sublibraries) were 
selected and tested in a dose-response manner. The most 
active mixtures were chosen, and all possible combinations 
of the building blocks used for the synthesis of individual 
compounds.  In this case, three building blocks were chosen 
for R1, four for R2 and four for R3.  The forty-eight (3 x 4 x 
4) individual bicyclic guanidines synthesized were then 
tested for activity and found to range from 37 to 10,000 nM 
7
. The most active individual bicyclic guanidine identified 
has an activity of (IC50 = 37 nM).  This same bicyclic 
guanidine PS-SCL has been screened to identify potent 
antifungal compounds. Each of the 141 mixtures was tested 
for its ability to inhibit Candida albicans growth in a 
standard microdilution assay.  Half of the generated 32 
individual compounds exhibited antifungal activity with 
minimum inhibitory concentrations (MIC) varying from 3 to 
10 µg/ml. 
The cyclic urea and thiourea libraries were assayed for 
their ability to inhibit Candida albicans growth, which is 
one of the most common opportunistic fungi responsible for 
infections and is the fungal infection most frequently 
associated with HIV-positive patients 7. Greater activities 
were found for the N-benzylated compounds relative to N-
methylated compounds (MIC values of the most active 
compounds varied from 8 to 64 µg/ml, and 64 to 125 µg/ml, 
respectively). 
In another example, a linear urea library has been 
prepared by the reaction of a resin-bound amino acid with 
individual isocyanates, affording the linear ureas in good 
yields. The library composed of 125,000 linear N, N’-
disubstituted ureas was prepared and has been tested for 
opioid activity in mu, delta, and kappa opioid and sigma 
receptor binding assays.  Following deconvolution of the 
library, individual compounds with 1-10 nM affinities at the 
mu and sigma receptors were found. Figure 1 presents 
examples of the identification of different active compounds 
from different libraries in a variety of assays. 
 
N N N
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CH3
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CH3
NH
CH3
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IC50: 0.5 nM
N
N
N
OH3C
CH3
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in Cancer Cells
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N N N
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N
H
OHN O
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N N HN
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N
H
N
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H2N CH3
OH3C
Br
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IC50: 42 µM
N N HN
S
NH
F
NH2
HN
MCH1 receptor antagonist
IC50: 6.1 nM
HN N
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N
N
N
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MIC = 2 µg/ml
% inhibition: 95
(Antitubercular)
 
Fig. 1. Examples of identified active compounds from small molecule mixture based libraries. 
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Highly active individual small molecule compounds 
were also identified from the N-benzyl-1,4,5-trisubstituted-
2,3-diketopiperazine library and the triphenylurea library in 
an assay to identify XIAP inhibitors based on the ability of 
the compounds to overcome the XIAP-mediated 
suppression of caspases (enzyme depression assay) 8.  Two 
different mixture-based positional scanning libraries made 
up of more than 30,000 compounds each were screened 
against P. falciparum and T. brucie rhodesiense.  Both 
libraries, namely N-methylated 1,3,4-trisubstituted 
piperazine and the N-methyl triamine, yielded good 
inhibitory activity in these assays.  Individual N-methyl 
amines and N-methyl piperazines were synthesized 
following the standard positional scanning deconvolution 
approach, and have been prepared for testing against T. 
brucie rhodesiense, and P. falciparum.  Bis-piperazine and 
bis-cyclic guanidine compounds demonstrated higher than 
90% inhibition in the primary antitubercular assay at low 
concentrations (MIC < 4 µg/ml). 
 
Conclusion 
We have described part of our work on the use of amino 
acids and peptides as precursors for the generation of 
combinatorial libraries. The use of the teabag approach for 
parallel array synthesis greatly facilitates the synthesis of 
the individual compounds, as well as mixture based 
combinatorial libraries. The application of the “libraries 
from libraries” concept has permitted the expansion of the 
number of combinatorial libraries with each new chemical 
transformation developed. The combination of these 
techniques advances, not only the synthesis of biologically 
relevant compounds, but also greatly facilitates the ultimate 
goal of medicinal chemistry: the identification of individual 
therapeutically useful molecules. 
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